133 related articles for article (PubMed ID: 9377586)
1. Intranasal versus intravenous neostigmine in myasthenia gravis: assessment by computer analysis of saccadic eye movements.
Di Costanzo A; Toriello A; Mannara C; Benvenuti C; Tedeschi G
Clin Neuropharmacol; 1993 Dec; 16(6):511-7. PubMed ID: 9377586
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibitor treatment for myasthenia gravis.
Mehndiratta MM; Pandey S; Kuntzer T
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD006986. PubMed ID: 25310725
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intranasal administration of neostigmine in myasthenic patients.
Sghirlanzoni A; Pareyson D; Benvenuti C; Cei G; Cosi V; Lombardi M; Nicora M; Ricciardi R; Cornelio F
J Neurol; 1992 Mar; 239(3):165-9. PubMed ID: 1573422
[TBL] [Abstract][Full Text] [Related]
4. Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.
Ricciardi R; Rossi B; Nicora M; Sghirlanzoni A; Muratorio A
J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1061-2. PubMed ID: 1783916
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase inhibitor treatment for myasthenia gravis.
Mehndiratta MM; Pandey S; Kuntzer T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006986. PubMed ID: 21328290
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study of neostigmine after intranasal and intravenous administration in the guinea pig.
Fossati A; Vimercati MG; Bandi GL; Formenti A
Drugs Exp Clin Res; 1990; 16(11):575-9. PubMed ID: 2101780
[TBL] [Abstract][Full Text] [Related]
7. Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD).
Chan PC; Tam SC; Cheng IK
Perit Dial Int; 1990; 10(1):93-6. PubMed ID: 2085592
[TBL] [Abstract][Full Text] [Related]
8. Post-varicella myasthenia gravis.
Saha A; Batra P; Vilhekar KY; Chaturvedi P
Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
[TBL] [Abstract][Full Text] [Related]
9. Administering Neostigmine as a Subcutaneous Infusion: A Case Report of a Patient Dying With Myasthenia Gravis.
Hindmarsh J; Woods E; Lee M; Pickard J
J Palliat Care; 2020 Apr; 35(2):78-81. PubMed ID: 31411109
[TBL] [Abstract][Full Text] [Related]
10. Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis.
Sciacca G; Reggio E; Mostile G; Nicoletti A; Drago F; Salomone S; Zappia M
Neurol Sci; 2018 Feb; 39(2):341-345. PubMed ID: 29330628
[TBL] [Abstract][Full Text] [Related]
11. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
12. [Triaminopteridine in the therapy of myasthenia gravis].
Mansoldo G; Battocchia A; De Candia O
Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
[No Abstract] [Full Text] [Related]
13. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
14. Continuous neostigmine infusion in post-thymectomy juvenile myasthenic crisis.
Briassoulis G; Hatzis T; Liakopoulou T; Youroukos S
J Child Neurol; 2000 Nov; 15(11):747-9. PubMed ID: 11108508
[TBL] [Abstract][Full Text] [Related]
15. Teaching neuroimages: reversible ectropion in myasthenia gravis.
Chang GY; Solé G; Ferrer X
Neurology; 2010 Apr; 74(15):1239; author reply 1239. PubMed ID: 20385900
[No Abstract] [Full Text] [Related]
16. Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis.
Chisari CG; Sciacca G; Reggio E; Terravecchia C; Patti F; Zappia M
Neurol Sci; 2023 Jul; 44(7):2555-2559. PubMed ID: 36971995
[TBL] [Abstract][Full Text] [Related]
17. [Myasthenia in childhood].
Portella A
Rass Int Clin Ter; 1967 Jan; 47(2):107-9. PubMed ID: 5629036
[No Abstract] [Full Text] [Related]
18. Changes in respiratory mechanics in myasthenia gravis with therapy. Counteracting effects of anticholinesterase.
Ringqvist I; Ringqvist T
Acta Med Scand; 1971 Dec; 190(6):509-18. PubMed ID: 5149095
[No Abstract] [Full Text] [Related]
19. HIV infection with myasthenia gravis.
Gorthi SP; Shankar S; Johri S; Mishra A; Chaudhary NR
J Assoc Physicians India; 2005 Nov; 53():995-6. PubMed ID: 16515244
[TBL] [Abstract][Full Text] [Related]
20. Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.
Ohry A
J Med Biogr; 2009 May; 17(2):73-4. PubMed ID: 19401508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
